Did you know that 1 in 4 dogs will develop some form of cancer in their lifetime? It’s a staggering statistic, but there is hope. Through clinical trial studies at The Ohio State University College of Veterinary Medicine. Clinical trials represent the cutting edge of medicine: research expertise meets new treatments and improved outcomes, including an improved understanding of the diseases, like cancer, that affect our animals. The Clinical Trials Office (CTO) at The Ohio State University College of Veterinary Medicine continues to be the largest and most comprehensive center for clinical trials involving client owned animals in the United States. More than 20 clinical trials are conducted yearly, typically involving over 600 animals.
There are many benefits to patients that participate in a clinical trial. Patients who are enrolled in clinical trials receive frequent monitoring, compassionate care and access to the latest, leading-edge therapies available. Clients may receive portions of their pets’ veterinary care at reduced rates or at no charge.
The Ohio State CTO has recently joined The Ohio State University Comprehensive Cancer Center (CCC) as a developing resource in an effort to improve translational oncology outcomes across species – human and animal alike.
The Ohio State CTO is also continuing to partner with Nationwide Children’s Hospital to study bone cancer (osteosarcoma) in both dogs and children with the hope of finding better treatments for this devastating disease. Earlier collaboration resulted in the successful application for a $10 million program project grant aimed at improving outcomes in childhood sarcoma. In addition, the CTO works with pharmaceutical companies across the U.S. to bring advanced diagnostic techniques and treatments for animals with a variety of diseases, with the ultimate goal of translating these findings into human medicine.
For more information visit our Clinical Trials web site: http://vet.osu.edu/vmc/clinical-trials